AMPAmeriprise Financial
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $12.07Beat
- vs $11.60 expected on Oct 29
- Stock move on it
- +1.65%
- one session
- Typical move
- ±1.5%
- average over 2 reports
- Price
- $515.57
- −0.86% today · $46.8B cap
Past and upcoming reports
2
| Oct 29, 2026 | Sep 30, 2026 | Time not given | $11.60 | Beat$12.07 | +1.65% |
| Jul 23, 2026 | Jun 30, 2026 | Time not given | $10.59 | Missed$9.11 | −1.27% |
After the report
Jul 23, 2026 report
This covers the Jul 23, 2026 report. The Oct 29, 2026 numbers are in the table above.
AMP misses EPS by 15%, stock rises 1.7% on forward optimism
Ameriprise Financial reported Q2 2026 EPS of $9.11, missing the $10.72 consensus by 15%. Despite the miss, the stock gained 1.7% on the day, suggesting the market is looking past the quarter and focusing on a cheap valuation (forward P/E 9.4x) and potential forward guidance. No explicit guidance was captured, but the price action implies a positive tone.
Reported against expected
MissedReported EPS $9.11 vs estimated $10.72, a miss of -15.0%.
Guidance
Not explicitly provided in payload. stock rose 1.7% post-print, implying market optimism on forward outlook.
How the stock reacted
Stock closed at $528.90, up 1.69% from previous close of $520.11, with volume of 343,401 shares.
What changed
EPS missed by 15%, but stock rose 1.7% on forward sentiment.
What the price now assumes
Market is pricing a cheap valuation (forward P/E 9.4x) and ignoring the one-time miss.
What it means for the business
Upgrade bias if forward guidance confirms. watch next quarter's EPS trajectory.
The next one to three months, as we saw it then
Better case30%
The EPS miss was due to one-time items. forward guidance and AUM growth drive earnings recovery, supported by cheap valuation and strong ROE (66.9%).
Base case50%
The miss is a one-off, but growth remains moderate (EPS growth TTM +36%, but forward 5Y +11.5%). Stock trades in a range as investors await clarity on earnings trajectory.
Worse case20%
The EPS miss signals underlying weakness. forward guidance disappoints, and the stock re-rates lower despite cheap valuation. Insider selling (-27.87% net over 6M) is a warning.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.